Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

8. Segment and Geographic Information (Tables)

8. Segment and Geographic Information (Tables)

9 Months Ended

Dec. 31, 2013

	Three Months				Nine Months
	Ended				Ended
	December 31,				December 31,
	2013		2012		2013		2012
U.S.	$	1,331,000	$	1,653,000	$	4,552,000	$	5,584,000
Mexico		1,237,000		1,356,000		4,013,000		4,596,000
Europe and Other		511,000		348,000		1,521,000		1,257,000
	$	3,079,000	$	3,357,000	$	10,086,000	$	11,437,000

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details